Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,767 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma

NCT04091750

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Medstar Franklin Square Medical Center, Harry and Jeanette Weinberg Cancer Institute Baltimore, Maryland, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

NCT06346067

Conditions
Advanced or Metastatic NRAS-mutant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • The Melanoma and Skin Care Institute Englewood, Colorado, United States
  • Mayo Clinic - Florida Jacksonville, Florida, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

NCT05907304

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

NCT04336241

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +25 more
Locations
  • Hospital Universitario d'Hebron Barcelona, Spain
  • Hospital Universitario HM Sanchinarro Madrid, Spain
  • Hospital Clinico de Valencia Valencia, Spain
  • The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Merseyside, United Kingdom
View Trial Details
Active, Not Recruiting

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

NCT01824875

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +23 more
Locations
  • Kaiser Anaheim Medical Center Anaheim, California, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Kaiser Permanente Medical Group - Baldwin Park Baldwin Park, California, United States
  • Kaiser Foundation Hospital Bellflower, California, United States
View all 323 locations
View Trial Details

Related conditions